Alar Pharmaceuticals Inc.

Alar Pharmaceuticals Inc.verified

6785.TWO

Price:

$288

Market Cap:

$19.24B

Alar Pharmaceuticals Inc., a drug development company, focuses on developing long-acting release drug products for CNS disorders and chronic diseases in Taiwan. It is developing ALA-1000, which is in Phase II clinical trials for the treatment of opioid use disorder; ALA-1300 and ALA-2000, which is in pre-clinical stage for opioid use disorder; ALA-4000 which is in pre-clinical stage for treatment of Parkinson's disease; and ALA-3000, which is in pre-clinical stage for treating treatment-resistant depression. Alar Pharmaceuticals Inc. was founded in 2016 and is based in Taichung, Taiwan.

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2020-10-05

Stock Exchange

TWO

Ticker

6785.TWO

The PE Ratio as of December 2025 (TTM) for Alar Pharmaceuticals Inc. (6785.TWO) is -654.55

According to Alar Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -654.55. This represents a change of 115.80% compared to the average of -303.32 of the last 4 quarters.

Alar Pharmaceuticals Inc. (6785.TWO) Historical PE Ratio (quarterly & annually)

How has 6785.TWO PE Ratio performed in the past?

The mean historical PE Ratio of Alar Pharmaceuticals Inc. over the last ten years is 7.77. The current -654.55 PE Ratio has changed -842299.49% with respect to the historical average. Over the past ten years (40 quarters), 6785.TWO's PE Ratio was at its highest in in the September 2023 quarter at 1.30K. The PE Ratio was at its lowest in in the June 2024 quarter at -1244.39.

Quarterly (TTM)
Annual

Average

7.77

Median

-23.05

Minimum

-329.88

Maximum

524.07

Alar Pharmaceuticals Inc. (6785.TWO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Alar Pharmaceuticals Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 1.57%

Maximum Annual PE Ratio = 524.07

Minimum Annual Increase = -109.51%

Minimum Annual PE Ratio = -329.88

Quarterly (TTM)
Annual
YearPE RatioChange
2024524.071.57%
202331.37-109.51%
2022-329.88712.52%
2021-40.60137.07%
2020-17.13-26.09%
2019-23.171.08%
2018-22.93-61.51%

Alar Pharmaceuticals Inc. (6785.TWO) Average PE Ratio

How has 6785.TWO PE Ratio performed in the past?

The current PE Ratio of Alar Pharmaceuticals Inc. (6785.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

75.19

5-year avg

33.57

10-year avg

7.77

Alar Pharmaceuticals Inc. (6785.TWO) PE Ratio vs. Peers

How is 6785.TWO’s PE Ratio compared to its peers?

Alar Pharmaceuticals Inc.’s PE Ratio is less than Grape King Bio Ltd (15.47), less than Handa Pharmaceuticals, Inc. (21.97), less than Synmosa Biopharma Corporation (20.94), less than TTY Biopharm Company Limited (13.25), less than YungShin Global Holding Corporation (15.94), less than Foresee Pharmaceuticals Co., Ltd. (-9.89), less than ScinoPharm Taiwan, Ltd. (71.28), less than TaiMed Biologics Inc. (-79.95), less than EirGenix Inc. (-27.20), less than Great Tree Pharmacy Co., Ltd. (23.16),

Build a custom stock screener for Alar Pharmaceuticals Inc. (6785.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alar Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Alar Pharmaceuticals Inc. (6785.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Alar Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Alar Pharmaceuticals Inc.'s PE Ratio?

How is the PE Ratio calculated for Alar Pharmaceuticals Inc. (6785.TWO)?

What is the highest PE Ratio for Alar Pharmaceuticals Inc. (6785.TWO)?

What is the 3-year average PE Ratio for Alar Pharmaceuticals Inc. (6785.TWO)?

What is the 5-year average PE Ratio for Alar Pharmaceuticals Inc. (6785.TWO)?

How does the current PE Ratio for Alar Pharmaceuticals Inc. (6785.TWO) compare to its historical average?